Fund the NHS to send a Prostate Risk Questionnaire to people at age 45, assessing prostate cancer risk and guiding them to monitor symptoms, speak to a nurse, or see their GP.
React
Members can read every reason.
Fund screening of prostate cancer for all men over 50, every 2 years
Fund screening for prostate cancer for all men over 50 years of age every 2 years. Men with higher PSA levels, higher risk or family history should be screened more frequently. Men over 70 years of age should be monitored on a case by case basis.
Fund annual prostate screening for all members of the UK Armed Forces
We call on the Government to fund a programme for annual prostate screening for all members of the UK Armed Forces to help protect our veterans and save lives.
Introduce a screening programme for prostate cancer, starting with high-risk men
We are calling on the Government to reassess the UK National Screening Committee’s (UK NSC) draft recommendation not to offer prostate cancer screening to anyone except men with BRCA1/2 genetic variants, and to introduce screening for all high-risk men.
Fund the NHS to send a Prostate Risk Questionnaire to people at age 45, assessing prostate cancer risk and guiding them to monitor symptoms, speak to a nurse, or see their GP.
React
Members can read every reason.
Fund screening of prostate cancer for all men over 50, every 2 years
Fund screening for prostate cancer for all men over 50 years of age every 2 years. Men with higher PSA levels, higher risk or family history should be screened more frequently. Men over 70 years of age should be monitored on a case by case basis.
Fund annual prostate screening for all members of the UK Armed Forces
We call on the Government to fund a programme for annual prostate screening for all members of the UK Armed Forces to help protect our veterans and save lives.
Introduce a screening programme for prostate cancer, starting with high-risk men
We are calling on the Government to reassess the UK National Screening Committee’s (UK NSC) draft recommendation not to offer prostate cancer screening to anyone except men with BRCA1/2 genetic variants, and to introduce screening for all high-risk men.